Founded
Address
Lilly Ventures
115 W. Washington Street
South Tower 1680
Indianapolis, IN 46204
United States
Phone
Website
Recent investment activity
Tags
KANDO id: 30096
Corporate information
Registration country
Funding rounds
Top investment portfolio themes
micro-VC (1)
Actual initial investment stage
N/A (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 36Company | Profile | Country | Date Sort descending | Funding | ||
---|---|---|---|---|---|---|
GlobeImmune Inc | Biopharmaceuticals company. | N/A | ||||
RelayHealth Corp | N/A | |||||
Trinity Biosystems Inc | Developer of a platform for the delivery of peptides across intact mucosal surfaces. | N/A | ||||
IRX Therapeutics Inc | N/A | |||||
Kanisa Pharmaceuticals Inc | Biopharmaceutical company employing a targeted approach to the diagnosis and treatment of cancer. | N/A | ||||
Anthera Pharmaceuticals Inc | N/A | |||||
Intradigm Corp | N/A | |||||
InCube Ventures LLC | Life science venture capital firm focused on investing in extraordinary innovations that solve unmet clinical needs for large patient populations. | N/A | ||||
Forma Therapeutics Inc | N/A | |||||
CGI Pharmaceuticals Inc | A biopharmaceutical company developing small molecule therapeutics for multiple oncology and immunology-based indications. | N/A | ||||
XenoPort Inc | N/A Initial investment | |||||
Serenex Inc | Oncology-focused drug development company | N/A | ||||
Conforma Therapeutics Corp | Novel drugs company for the selective treatment of cancer. | N/A | ||||
MedManage Systems Inc | Online drug sampling provider | N/A | ||||
Aileron Therapeutics Inc | Developing a breakthrough proprietary peptide technology platform | N/A | ||||
Hydra Biosciences Inc | N/A | |||||
Bayhill Therapeutics | A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. | N/A | ||||
Viamet Pharmaceuticals Inc | N/A | |||||
Remon Medical Technologies Inc | Medical device company providing smart, miniature implants. | Series C | ||||
Avid Radiopharmaceuticals Inc | Series A | |||||
InnoCentive Inc | Series A | |||||
Cabrellis Pharmaceuticals Corp | Development of important therapies for the treatment of cancer | Series A | ||||
Protagonist Therapeutics Inc | Biotechnology company dedicated to the discovery of novel peptide and small molecule compounds. | Series A | ||||
Fluidigm Corp | Developer and manufacturer of microfluidic systems for markets in the life science and agricultural biotechnology industries. | Series E | ||||
Cylene Pharmaceuticals Inc | Clinical stage private company developing small molecule drugs against newly validated cancer targets. | Series C |
Pagination
Team
Employee | Position | |||
---|---|---|---|---|
S Edward Torres | [email protected] |